Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 222

    1.

    Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial.

    Cordonnier C, Chevret S, Legrand M, Rafi H, Dhédin N, Lehmann B, Bassompierre F, Gluckman E; GREFIG Study Group.

    Ann Intern Med. 2003 Jul 1;139(1):8-18.PMID: 12834313 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.

    Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.

    Bone Marrow Transplant. 2001 Jul;28(2):187-96.PMID: 11509937 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

    Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, Gallez-Hawkins G, Cunningham T, Blume KG, Levitt D, Zaia JA.

    Biol Blood Marrow Transplant. 2001;7(6):343-51.PMID: 11464977 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.

    Essell JH, Schroeder MT, Harman GS, Halvorson R, Lew V, Callander N, Snyder M, Lewis SK, Allerton JP, Thompson JM.

    Ann Intern Med. 1998 Jun 15;128(12 Pt 1):975-81.PMID: 9625683 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Summaries for patients. Immunoglobulin in patients with stem-cell transplants.

    [No authors listed]

    Ann Intern Med. 2003 Jul 1;139(1):I-45. No abstract available. PMID: 12834334 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).

    Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A.

    Haematologica. 1998 Feb;83(2):132-7.PMID: 9549924 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.

    List AF, Maziarz R, Stiff P, Jansen J, Liesveld J, Andrews F, Schuster M, Wolff S, Litzow M, Karanes C, Dahlberg S, Kirkhart B, Bianco JA, Singer JW.

    Bone Marrow Transplant. 2000 Feb;25(3):283-91.PMID: 10673700 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

    Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

    Ann Intern Med. 2003 May 6;138(9):705-13.PMID: 12729424 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.

    Joshi SS, Bishop MR, Lynch JC, Tarantolo SR, Abhyankar S, Bierman PJ, Vose JM, Geller RB, McGuirk J, Foran J, Bociek RG, Hadi A, Day SD, Armitage JO, Kessinger A, Pavletic ZS.

    Cytotherapy. 2003;5(6):542-52.PMID: 14660050 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

    Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M; Boston Center for Liver Transplantation CMVIG Study Group.

    Ann Intern Med. 1993 Nov 15;119(10):984-91.PMID: 8214995 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation.

    Raanani P, Gafter-Gvili A, Paul M, Ben-Bassat I, Leibovici L, Shpilberg O.

    Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006501. Review.PMID: 18843719 [PubMed - indexed for MEDLINE]Related articles

    12.

    Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?

    Klaesson S, Ringdén O, Ljungman P, Aschan J, Hägglund H, Winiarski J.

    Transplantation. 1995 Dec 15;60(11):1225-30.PMID: 8525515 [PubMed - indexed for MEDLINE]Related articles

    13.

    Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.

    Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA.

    Blood. 2006 Mar 1;107(5):1800-5. Epub 2005 Nov 10.PMID: 16282339 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A comparison of allografting with autografting for newly diagnosed myeloma.

    Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Giaccone L, Sorasio R, Omedè P, Baldi I, Bringhen S, Massaia M, Aglietta M, Levis A, Gallamini A, Fanin R, Palumbo A, Storb R, Ciccone G, Boccadoro M.

    N Engl J Med. 2007 Mar 15;356(11):1110-20.PMID: 17360989 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.

    Feinstein LC, Seidel K, Jocum J, Bowden RA, Anasetti C, Deeg HJ, Flowers ME, Kansu E, Martin PJ, Nash RA, Storek J, Etzioni R, Applebaum FR, Hansen JA, Storb R, Sullivan KM.

    Biol Blood Marrow Transplant. 1999;5(6):369-78.PMID: 10595814 [PubMed - indexed for MEDLINE]Related articles

    16.

    Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.

    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.

    Klin Padiatr. 2005 May-Jun;217(3):135-41.PMID: 15858704 [PubMed - indexed for MEDLINE]Related articles

    17.

    Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality.

    Cantoni N, Weisser M, Buser A, Arber C, Stern M, Heim D, Halter J, Christen S, Tsakiris DA, Droll A, Frei R, Widmer AF, Flückiger U, Passweg J, Tichelli A, Gratwohl A.

    Eur J Haematol. 2009 Aug;83(2):130-8. Epub 2009 Mar 5.PMID: 19284419 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.

    Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M, Parkkali T, Hägglund H, Ringdén O; Nordic Bone Marrow Transplantation Group.

    Blood. 2002 Sep 15;100(6):1977-83.PMID: 12200355 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.

    Cornelissen JJ, van der Holt B, Petersen EJ, Vindelov L, Russel CA, Höglund M, Maertens J, Schouten HC, Braakman E, Steijaert MM, Zijlmans MJ, Slaper-Cortenbach I, Boogaerts MA, Löwenberg B, Verdonck LF.

    Exp Hematol. 2003 Oct;31(10):855-64.PMID: 14550800 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.

    Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ, et al.

    Bone Marrow Transplant. 1995 Jun;15(6):949-54.PMID: 7581096 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data